Work

Abstract 3790: Preclinical assessment of valemetostat, a dual inhibitor of EZH2 and EZH1, combined with trastuzumab deruxtecan and datopotamab deruxtecan for multiple solid tumors

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-3790

Authors: Daisuke Honma, Akiko Toyota, Yasuhiro Hama, Yasuki Kamai, Daisuke Okajima, Yoshiyuki Hizukuri, Maiko Narahara, Yuka Yamamoto, Emi Nosaka, Katsuki Usami, Kazumi Sato, Hiroki Goto, Ayumi Tezuka, Ayako Kato, Chisa Wada, Naoya Wada, Megumi Minami, Hideki Kobayashi, Mayumi Kitagawa

Institutions: Daiichi-Sankyo (Japan), Daiichi Sankyo (United States)

Language: English

Topic: Epigenetics and DNA Methylation

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409688769

Cites:

Cited by: 1

Related to: 10